Many a CFO has lost more than a night’s sleep contemplating both the intended and unintended consequences of new healthcare regulations.  Because of the uncertainty that’s been created, the paralysis is virtually palpable. While the ultimate impact...

Last week, Safeguard Scientifics’ Life Sciences team attended J.P. Morgan’s 29th Annual Healthcare Conference and OneMedForumSF 2011 (video) in San Francisco. Our main takeaway is that the healthcare industry is still alive. From an investment...

Last year around this time, as we headed into 2010 and were making plans for the coming year, we were in the midst of the most significant market meltdown since 1929-1938, a lingering credit crunch, an economy hindered by persistent unemployment and a...

Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR team has a never-ending challenge to articulate, to new and existing institutional and retail...

This week, our life sciences team is heading out to San Francisco to attend J.P. Morgan’s 29th Annual Healthcare Conference, one of the life science industry’s largest and most important annual gatherings. This year, conference coordinators have estimated...